# Clifutinib Food Effect Study in Healthy Subjects

> **NCT05454098** · PHASE1 · COMPLETED · sponsor: **Sunshine Lake Pharma Co., Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Acute Myeloid Leukemia in Children

## Interventions

- **DRUG:** Clifutinib with fed state
- **DRUG:** Clifutinib with fasted state

## Key facts

- **NCT ID:** NCT05454098
- **Lead sponsor:** Sunshine Lake Pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-08
- **Primary completion:** 2022-12-08
- **Final completion:** 2022-12-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05454098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05454098, "Clifutinib Food Effect Study in Healthy Subjects". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05454098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*